company background image
A034940 logo

ChoA Pharmaceutical KOSDAQ:A034940 Stock Report

Last Price

₩960.00

Market Cap

₩29.2b

7D

0.6%

1Y

-53.5%

Updated

22 Nov, 2024

Data

Company Financials

ChoA Pharmaceutical Co., LTD.

KOSDAQ:A034940 Stock Report

Market Cap: ₩29.2b

A034940 Stock Overview

ChoA Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea. More details

A034940 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

ChoA Pharmaceutical Co., LTD. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for ChoA Pharmaceutical
Historical stock prices
Current Share Price₩960.00
52 Week High₩2,150.00
52 Week Low₩888.00
Beta0
11 Month Change-30.38%
3 Month Change-34.87%
1 Year Change-53.51%
33 Year Change-73.22%
5 Year Change-75.19%
Change since IPO-52.48%

Recent News & Updates

ChoA Pharmaceutical (KOSDAQ:034940) Is Carrying A Fair Bit Of Debt

Nov 12
ChoA Pharmaceutical (KOSDAQ:034940) Is Carrying A Fair Bit Of Debt

Would ChoA Pharmaceutical (KOSDAQ:034940) Be Better Off With Less Debt?

Aug 12
Would ChoA Pharmaceutical (KOSDAQ:034940) Be Better Off With Less Debt?

Recent updates

ChoA Pharmaceutical (KOSDAQ:034940) Is Carrying A Fair Bit Of Debt

Nov 12
ChoA Pharmaceutical (KOSDAQ:034940) Is Carrying A Fair Bit Of Debt

Would ChoA Pharmaceutical (KOSDAQ:034940) Be Better Off With Less Debt?

Aug 12
Would ChoA Pharmaceutical (KOSDAQ:034940) Be Better Off With Less Debt?

ChoA PharmaceuticalLtd (KOSDAQ:034940) Has A Pretty Healthy Balance Sheet

Jan 31
ChoA PharmaceuticalLtd (KOSDAQ:034940) Has A Pretty Healthy Balance Sheet

Did You Miss ChoA PharmaceuticalLtd's (KOSDAQ:034940) 36% Share Price Gain?

Dec 09
Did You Miss ChoA PharmaceuticalLtd's (KOSDAQ:034940) 36% Share Price Gain?

Shareholder Returns

A034940KR PharmaceuticalsKR Market
7D0.6%-1.5%2.4%
1Y-53.5%4.6%-4.0%

Return vs Industry: A034940 underperformed the KR Pharmaceuticals industry which returned 4.6% over the past year.

Return vs Market: A034940 underperformed the KR Market which returned -4% over the past year.

Price Volatility

Is A034940's price volatile compared to industry and market?
A034940 volatility
A034940 Average Weekly Movement6.2%
Pharmaceuticals Industry Average Movement5.2%
Market Average Movement5.6%
10% most volatile stocks in KR Market11.5%
10% least volatile stocks in KR Market2.7%

Stable Share Price: A034940 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A034940's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1964254Sung-Hwan Chowww.choa.co.kr

ChoA Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea. The company produces approximately 200 medicines and health foods, including 30 internal ampoule products, such as Hepos, Fematin, Vasoclean, Mabis, etc. Its products include drugs for digestive, circulatory, and respiratory systems; vitamins, minerals, and nutrients; anti inflammation and analgesics; peripheral nervous system; gynecologic diseases; antibiotics, antigens, and anthelmintic; and antitumor, as well as other metabolite medicines. The company offers its products in the form of tablets, capsules, granules, syrups, solutions, drinkable ampoules, and sachets.

ChoA Pharmaceutical Co., LTD. Fundamentals Summary

How do ChoA Pharmaceutical's earnings and revenue compare to its market cap?
A034940 fundamental statistics
Market cap₩29.21b
Earnings (TTM)-₩13.07b
Revenue (TTM)₩61.46b

0.5x

P/S Ratio

-2.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A034940 income statement (TTM)
Revenue₩61.46b
Cost of Revenue₩40.36b
Gross Profit₩21.10b
Other Expenses₩34.17b
Earnings-₩13.07b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-421.95
Gross Margin34.33%
Net Profit Margin-21.27%
Debt/Equity Ratio69.8%

How did A034940 perform over the long term?

See historical performance and comparison